venBio Select Advisor as of Sept. 30, 2018
Portfolio Holdings for venBio Select Advisor
venBio Select Advisor holds 45 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Immunomedics | 16.9 | $369M | 18M | 20.83 | |
| Mirati Therapeutics | 10.4 | $226M | 4.8M | 47.10 | |
| Sarepta Therapeutics (SRPT) | 7.0 | $152M | 944k | 161.51 | |
| Ascendis Pharma A S (ASND) | 6.4 | $139M | 2.0M | 70.86 | |
| BioMarin Pharmaceutical (BMRN) | 6.1 | $133M | 1.4M | 96.97 | |
| Amicus Therapeutics (FOLD) | 5.2 | $113M | 9.3M | 12.09 | |
| Madrigal Pharmaceuticals (MDGL) | 4.5 | $99M | 463k | 214.13 | |
| Iovance Biotherapeutics (IOVA) | 4.5 | $98M | 8.7M | 11.25 | |
| Endocyte | 4.3 | $94M | 5.3M | 17.76 | |
| Horizon Pharma | 4.0 | $87M | 4.5M | 19.58 | |
| Zogenix | 3.3 | $72M | 1.5M | 49.60 | |
| Amarin Corporation (AMRN) | 3.0 | $66M | 4.0M | 16.27 | |
| Argenx Se (ARGX) | 2.6 | $57M | 755k | 75.84 | |
| Tricida | 2.5 | $54M | 1.8M | 30.55 | |
| Puma Biotechnology (PBYI) | 2.4 | $53M | 1.2M | 45.85 | |
| Assembly Biosciences | 1.8 | $39M | 1.0M | 37.14 | |
| Clovis Oncology | 1.6 | $34M | 1.1M | 29.37 | |
| Ptc Therapeutics I (PTCT) | 1.5 | $32M | 684k | 47.00 | |
| Xenon Pharmaceuticals (XENE) | 1.4 | $31M | 2.4M | 13.20 | |
| Tg Therapeutics (TGTX) | 1.1 | $24M | 4.2M | 5.60 | |
| Teligent | 1.0 | $21M | 5.3M | 3.95 | |
| Pacira Pharmaceuticals (PCRX) | 0.9 | $20M | 413k | 49.15 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.8 | $17M | 4.5M | 3.78 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.8 | $16M | 850k | 19.17 | |
| BioDelivery Sciences International | 0.7 | $15M | 5.4M | 2.80 | |
| Intec Pharma | 0.7 | $15M | 2.6M | 5.65 | |
| Sesen Bio | 0.7 | $15M | 6.8M | 2.15 | |
| Establishment Labs Holdings Ord (ESTA) | 0.5 | $11M | 475k | 24.10 | |
| Global Blood Therapeutics In | 0.5 | $11M | 288k | 38.00 | |
| Vanda Pharmaceuticals (VNDA) | 0.5 | $9.9M | 430k | 22.95 | |
| Acer Therapeutics | 0.4 | $8.6M | 280k | 30.84 | |
| Fennec Pharmaceuticals (FENC) | 0.4 | $8.4M | 1.0M | 8.20 | |
| Y Mabs Therapeutics (YMAB) | 0.4 | $8.2M | 310k | 26.56 | |
| Crispr Therapeutics (CRSP) | 0.3 | $6.5M | 147k | 44.35 | |
| Alimera Sciences | 0.3 | $6.1M | 6.2M | 0.98 | |
| Tesaro | 0.3 | $5.9M | 150k | 39.01 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.1 | $2.6M | 6.0M | 0.44 | |
| ACADIA Pharmaceuticals (ACAD) | 0.1 | $2.1M | 100k | 20.76 | |
| Principia Biopharma | 0.1 | $2.2M | 75k | 29.23 | |
| Dbv Technologies S A (DBVT) | 0.1 | $1.2M | 54k | 22.46 | |
| SPDR S&P Biotech (XBI) | 0.0 | $780k | 1.5M | 0.52 | |
| Oncosec Med | 0.0 | $700k | 500k | 1.40 | |
| Oncobiologics | 0.0 | $670k | 684k | 0.98 | |
| Invesco Qqq Trust Series 1 (QQQ) | 0.0 | $175k | 500k | 0.35 | |
| Oncobiologics Inc *w exp 02/18/201 | 0.0 | $2.3k | 233k | 0.01 |
